APA (7th ed.) Citation

WB, M., J, Y., K, B., DC, S., G, S., K, S., . . . AL, C. (2024). D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide. Neuro-oncology advances, 6(1), vdae063. https://doi.org/10.1093/noajnl/vdae063

Chicago Style (17th ed.) Citation

WB, McKean, Yang J, Boucher K, Shrieve DC, Suneja G, Salzman K, Jensen R, Colman H, and Cohen AL. "D-TERMINED, a Phase 1 Trial in Newly Diagnosed High-grade Glioma with Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/temozolomide." Neuro-oncology Advances 6, no. 1 (2024): vdae063. https://doi.org/10.1093/noajnl/vdae063.

MLA (9th ed.) Citation

WB, McKean, et al. "D-TERMINED, a Phase 1 Trial in Newly Diagnosed High-grade Glioma with Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/temozolomide." Neuro-oncology Advances, vol. 6, no. 1, 2024, p. vdae063, https://doi.org/10.1093/noajnl/vdae063.